NEW YORK (GenomeWeb) – Trovagene said after the close of the market on Thursday that its second quarter revenues were up 14 percent year over year as it sharply narrowed its losses.

The San Diego firm posted $56,000 in revenues for the three months ended June 30, up from $49,000 in the year-ago quarter ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.